BioSpace News Archive

Modular Medical, Inc. today announced that Jeb Besser, CEO, is scheduled to present at the Sidoti Micro-Cap Virtual Conference on August 17.

Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced financial results for the second quarter ended June 30, 2023.

Arcutis Biotherapeutics, Inc. and Hangzhou Zhongmei Huadong Pharmaceutical Co, a wholly owned subsidiary of Huadong Medicine Co., Ltd., announced that the companies have entered into a strategic collaboration and licensing agreement for the development, manufacture, and commercialization of topical roflumilast in Greater China and Southeast Asia.

Molecular Templates, Inc. today reported financial results and business updates for the second quarter of 2023.

Microbot Medical Inc., the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic system, announces the expansion of its global team of experts supporting the Company as scientific advisory board members, with Francois H. Cornelis, MD, PhD joining Microbot’s SAB.

GeneFab, LLC, a contract research, development and manufacturing organization partnering with the cell and gene therapy industry and backed by private equity firm Celadon Partners, LLC, announced a transaction with Senti Biosciences, Inc. in which GeneFab would sublease Senti Bio’s current good manufacturing practice facility, a portion of which is subject to certain conditions.

Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell targeting therapies based on its proprietary Alluminox™ platform announces an exclusive licensing and commercialization agreement with Hikma Pharmaceuticals PLC, a multinational pharmaceutical company for the Middle East and North Africa.

ABVC BioPharma, Inc. announced today that on August 08, 2023, it received a letter from the Nasdaq Listing Qualifications Department notifying the Company that it had regained compliance with the minimum bid price requirement.

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Monday, August 14, 2023 at 8:30 a.m. Eastern Daylight Time to review second-quarter 2023 financials and provide corporate updates.

A study published August 10, 2023 in the journal Nature Communications has identified a new pathway that human immunodeficiency virus (HIV) uses to enter the nucleus of a healthy cell, where it can then replicate and go on to invade other cells.